Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- J S Elborn, M.D.
Queens University, Belfast, Northern Ireland, United Kingdom
Principal Investigator - James Chmiel, M.D.
University Hospitals Cleveland Medical Center, Cleveland, OH
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital Erasme
Brussels, Belgium
- Hôpital Arnaud de Villeneuve
Montpellier, France
- Institution Hôpital Pasteur
Nice, France
- Centre de Perharidy
Roscoff, France
- Christiane Herzog Cf-Zentrum Frankfurt Am Main
Frankfurt am Main, Hesse, Germany
- Uni Essen Abt.Pneumologie
Essen, North Rhine-Westphalia, Germany
- Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico
Milan, Italy
- Fondazione Irccs Cà Granda Ospedale Maggiore Policlinico
Milan, Italy
- Aoui Di Verona - Ospedale Borgo Trento Uoc Fibrosi Cistica
Verona, Italy
- Szpital Dziecięcy Polanki Im. Macieja Płażyńskiego W Gdańsku Spółka Z O.O. Poradnia Leczenia Mukowiscydozy
Gdansk, Poland
- Sanatorium Cassia-Villa Medica S.C
Rabka-Zdrój, Poland
- Podkarpacki Ośrodek Pulmunologii I Alergologii
Rzeszów, Poland
- Instytut Gruźlicy I Chorób Płuc I Klinika Chorób Płuc
Warsaw, Poland
- Belfast City Hospital
Belfast, United Kingdom
- Queen Elizabeth University Hospital
Glasgow, United Kingdom
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Long Beach Memorial Medical Center/miller Children'S and Women'S Hospital
Long Beach, California, United States
- National Jewish Health
Denver, Colorado, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Rutgers Robert-Wood Johnson Medical School
New Brunswick, New Jersey, United States
- North Shore Lij Health System
New Hyde Park, New York, United States
- New York Medical College
Valhalla, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- the University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Texas Children'S Hospital Clinical Care Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Sept 2015
- Primary completion
- 28 Dec 2016
- Completion
- 28 Dec 2016
- Last update posted
- 4 Apr 2018
- Registered enrollment
- 85
- Registry id
- NCT02465450
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.